Q3 2019 13F Holders as of 9/30/2019
-
Type / Class
-
Equity / COM NEW
-
Number of holders
-
59
-
Total 13F shares, excl. options
-
11.6M
-
Shares change
-
+621K
-
Total reported value, excl. options
-
$45.6M
-
Value change
-
+$2.34M
-
Put/Call ratio
-
1.21
-
Number of buys
-
29
-
Number of sells
-
-18
-
Price
-
$3.94
Significant Holders of Niagen Bioscience, Inc. - COM NEW (NAGE) as of Q3 2019
68 filings reported holding NAGE - Niagen Bioscience, Inc. - COM NEW as of Q3 2019.
Niagen Bioscience, Inc. - COM NEW (NAGE) has 59 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 11.6M shares
.
Largest 10 shareholders include BlackRock Inc. (2.32M shares), VANGUARD GROUP INC (1.89M shares), ICONIQ Capital, LLC (1.71M shares), Tieton Capital Management, LLC (1.42M shares), Uniplan Investment Counsel, Inc. (670K shares), STATE STREET CORP (601K shares), NORTHERN TRUST CORP (446K shares), GEODE CAPITAL MANAGEMENT, LLC (433K shares), FIRST REPUBLIC INVESTMENT MANAGEMENT, INC. (278K shares), and UBS Group AG (210K shares).
This table shows the top 59 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.